Skip to main content
NIH funding notice RFA-AI-22-003

Nonhuman Primate Transplantation Tolerance Cooperative Study Group (U19 Clinical Trial Not Allowed)

Closed on May 13, 2022.

Posted
January 18, 2022
Close date
May 13, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $10,396,882 in first-year total cost, median $3,485,857.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 AM-I (J1)]3

Most frequent institutions

  1. DUKE UNIVERSITY1
  2. MASSACHUSETTS GENERAL HOSPITAL1
  3. UNIVERSITY OF MINNESOTA1
Competing awards under RFA-AI-22-003 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Advancing Transplantation Tolerance in Nonhuman Primates1U19AI174966-01ADAMS, ANDREW BHERING, BERNHARD JOSEFLARSEN, CHRISTIAN P.UNIVERSITY OF MINNESOTA, MN$3,635,295ZAI1
2023Novel Approaches to Inducing Lung Allograft Tolerance in NHPs1U19AI174967-01MADSEN, JOREN CMASSACHUSETTS GENERAL HOSPITAL, MA$3,485,857ZAI1
2023The Risks and Opportunities of Homeostatic Repopulation2U19AI131471-07KNECHTLE, STUART JOHNSTONDUKE UNIVERSITY, NC$3,275,730ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AI-22-003: Nonhuman Primate Transplantation Tolerance Cooperative Study Group (U19 Clinical Trial Not Allowed) | ScienceDex | ConductScience